Scientists prevent preterm birth caused by gene-environment interactions

August 27, 2013

New research in the Journal of Clinical Investigation provides evidence that gene-environment interactions are a major contributor to preterm birth and that using a combinatory treatment strategy can prevent preterm delivery in a mouse model.

In findings posted online Aug. 27, scientists from Cincinnati Children's Hospital Medical Center say their study provides important new insights into a major global health problem – one that remains stubbornly persistent in the United States. Preterm birth causes more than 1 million deaths a year and can leave who survive with lifelong medical challenges ranging from to developmental problems.

The study was led by Sudhansu K. Dey, PhD, director of Reproductive Sciences at Cincinnati Children's, first author Jeeyeon Cha, an MD/PhD graduate student in the Dey lab, and Yasushi Hirota, MD/PhD, a former postdoctoral fellow in the Dey lab and faculty member at the Department of Obstetrics & Gynecology in the Graduate School of Medicine at the University of Tokyo.

The combined impact of genetic predisposition and environmental stress on preterm birth has received increased attention by researchers to determine its causes and potential preventive strategies. Scientists in the current study tested gene-environment interactions in a robust mouse model of prematurity and identified a similar molecular signature in human tissue samples from women who experienced premature birth.

"Although gene-environment interactions are assumed to be major contributors to preterm birth, this concept had not been experimentally interrogated," said Dey. "Our studies in mice provide evidence that when a genetic predisposition is combined with mild inflammation, the rate of preterm birth is profoundly increased, provoking preterm birth in 100 percent of the females."

"The results are also clinically relevant because aspects of the molecular signatures observed in the mouse studies are consistent with those observed in tissue samples of women who had undergone preterm birth," he added.

A recent report from the World Health Organization states that while more than 60 percent of preterm births occur in developing countries, the U.S. is among ten countries with the highest numbers of preterm birth. Dey and his colleagues said this suggests that factors behind preterm birth in developing and developed countries may be different. Infection/inflammation may affect developing countries more, while chronic diseases such as diabetes and hypertension and the increased use of assisted reproductive technologies in older women may increase prematurity rates in developed countries.

To conduct their research, the investigators generated a of preterm delivery in which the Trp53 gene was conditionally inactivated in the uterus. Trp53 encodes the p53 protein, which is a tumor suppressor and regulates cell growth and replication.

Through a series of studies, the scientists have reported these mice exhibit a preterm birth rate of 50 percent just from the genetic deletion. The scientists have also shown the mice exhibit increased signaling by mammalian target of rapamycin complex 1 (mTORC1) and cyclooxygenase-2 (COX2), which generates fatty acids called prostaglandins that trigger uterine contractions. These pathways are associated with premature senescence of uterine decidual cells, provoking spontaneous early birth.

In the current study, Trp53-deficient females were subjected to mild inflammation with LPS (endotoxin), resulting in a preterm birth rate of 100 percent. They also observed that women who had experienced preterm birth showed similar increases in mTORC1 and COX2 signaling.

The scientists then designed an experimental to prevent preterm birth in Trp53-deficient mice exposed to LPS – a combination of rapamycin (an mTORC1 inhibitor) and progesterone, an ovarian hormone necessary for pregnancy success. They report the treatment was effective at preventing preterm birth with no apparent adverse effects on maternal or fetal health.

Progesterone is currently in clinical use to prevent preterm birth in select populations of at-risk women. Although further in-depth investigation is required, the scientists suggest that a combined therapy with low doses of an mTORC1 inhibitor and progesterone may help reduce the incidence of in high-risk women.

Explore further: Study finds residence in US a risk factor for preterm birth

Related Stories

Study finds residence in US a risk factor for preterm birth

February 9, 2012
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that duration of stay in the United States ...

Researchers find possible therapeutic strategy to combat premature birth

October 24, 2011
Scientists who developed a novel mouse model mimicking human preterm labor have described a molecular signaling pathway underlying preterm birth and targeted it to stop the problem.

Study suggests genetic predisposition to brain injury after preterm birth is sex-specific

February 11, 2013
In a study to be presented on February 14 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Francisco, researchers will report that variation in a gene involved in inflammation is ...

Modern methods of abortion are not linked with an increased risk of preterm birth

July 9, 2013
The link between previous termination of pregnancy (abortion) and preterm delivery in a subsequent pregnancy has disappeared over the last 20-30 years, according to a study of data from Scotland published in this week's PLOS ...

Study shows progesterone fails to prevent preterm birth in high risk group

October 18, 2012
(Medical Xpress)—A formulation of the hormone progesterone, shown to be effective in women at risk for another preterm birth because they had a prior preterm birth, was not found to be effective in preventing preterm birth ...

Obesity increases the risk of preterm delivery

June 11, 2013
The risk of preterm delivery increases with maternal overweight and obesity, according to a new Swedish study published in Journal of the American Medical Association (JAMA). Women with the highest Body Mass Index (BMI) also ...

Recommended for you

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly identified genetic marker may help detect high-risk flu patients

July 17, 2017
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism ...

Newly discovered gene variants link innate immunity and Alzheimer's disease

July 17, 2017
Three new gene variants, found in a genome wide association study of Alzheimer's disease (AD), point to the brain's immune cells in the onset of the disorder. These genes encode three proteins that are found in microglia, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

FromHopeToJoy
not rated yet Aug 29, 2013
It would be amazing if the majority of premature deliveries could be prevented! My daughter Joy was born at 23 weeks last year. Due to modern medicine and prayers she is doing great today. I hemorrhaged at 17 weeks for the first of 4 times because of 100% placenta previa, which turned into placenta accreta (which I believe was caused by 3 prior c-sections). After she came home from 121 days in the NICU, I wrote a memoir called "From Hope To Joy" about my life-threatening pregnancy and my daughter's 4 months in the NICU (with my 3 young sons at home), which is now available on Amazon. It was quite a roller coaster that I am certain some of you have been on or are currently riding on. My goal of writing our memoir is to give a realistic look at what lies ahead to families with preemies in the NICU while showing them that hope can turn into Joy and that miracles can happen. Please see my website www.micropreemie.net and www.facebook.com/jenniferdegl
Thank you.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.